Among the 10 Antiretrovirals with the Highest Part D Spending in 2017, All Had List Price Increases Exceeding Inflation
All 10 Part D ARVs w Highest Spending Had Price Increases Above Inflation Download…
View the Latest: Medicare Part D
Filter
-
-
Medicare Part D at Ten Years: The 2015 Marketplace and Key Trends, 2006-2015
ReportSince 2006, Medicare beneficiaries have had access through Medicare Part D to prescription drug coverage offered by private plans, either stand-alone prescription drug plans (PDPs) or Medicare Advantage prescription drug plans (MA-PD plans). Now in its tenth year, Part D has evolved due to changes in the private plan marketplace and the laws and regulations that govern the program. This report presents findings from an analysis of the Medicare Part D marketplace in 2015 and changes in features of the drug benefit offered by Part D plans since 2006.
-
Medicare’s Income-Related Premiums Under Current Law and Changes for 2019
Issue BriefMost people with Medicare pay the standard monthly premium for Part B and Part D coverage, which is set to cover 25 percent of per capita program costs, but a relatively small share of beneficiaries with higher incomes are required to pay higher premiums. This issue brief describes the legislative history of Medicare's income-related premiums and changes to these premiums that will take effect in 2019, based on a provision in the Bipartisan Budget Act of 2018.
-
Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs
Event Date:EventThis report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. The analysis is based on a model developed by the Actuarial Research Corporation for the Kaiser Family Foundation.
-
Prospects for Retiree Health Benefits as Medicare Drug Coverage Begins – Report
ReportProspects for Retiree Health Benefits as Medicare Drug Coverage Begins:Findings from the Kaiser/Hewitt 2005 Survey on Retiree Health Benefits - Report This report assesses how large businesses that provide retiree health benefits to their workers are responding to the new Medicare drug benefit in 2006, their plans for the future, and the way these responses…
-
Toplines: National Survey of Physicians, Findings on Medicare Part D
Poll FindingThese toplines provide the results of a 2006 national survey of physicians on their views and experiences related to the new Medicare drug benefit. Topline (.
-
2001 Retiree Health and Prescription Drug Coverage Survey-6020
Report2001 Retiree Health and Prescription Drug Coverage Survey This survey, released by the Kaiser Family Foundation, The Commonwealth Fund, and HRET, profiles retiree health coverage for Medicare-age (65+) retirees, including the amount retirees pay for coverage compared to active workers, cost-sharing for prescription drugs, and eligibility requirements for retiree benefits.
-
Resources on the Medicare Prescription Drug Benefit: Medicare Part D Data Spotlights
Other PostTo better understand the private plans providing drug coverage to Medicare beneficiaries under the Part D benefit, the Kaiser Family Foundation has issued a series of data spotlights analyzing key elements of Medicare's private drug plans.
-
Recent Trends in GLP-1 Use and Spending in Medicare
Issue BriefAhead of the Trump administration’s planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicare’s negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMS’s Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.
-
Medicare Advantage 2017 Spotlight: Enrollment Market Update
Issue BriefThis Data Spotlight reviews national and state-level enrollment trends as of March 2017 and examines variation in enrollment by plan type and firm. It analyzes the most recent data on premiums, out-of-pocket limits, Part D cost-sharing for drugs, and plans’ quality ratings for Medicare Advantage enrollees.